Allspring Global Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Sell |
100,382
-1,555
| -2% | -$87.4K | 0.01% | 863 |
|
|
2025
Q1 | $6.93M | Buy |
101,937
+1,452
| +1% | +$98.6K | 0.01% | 827 |
|
|
2024
Q4 | $6.68M | Buy |
100,485
+103
| +0.1% | +$6.85K | 0.01% | 869 |
|
|
2024
Q3 | $7.06M | Buy |
100,382
+124
| +0.1% | +$8.72K | 0.01% | 855 |
|
|
2024
Q2 | $8.25M | Sell |
100,258
-21
| -0% | -$1.73K | 0.01% | 818 |
|
|
2024
Q1 | $8.76M | Buy |
100,279
+39,708
| +66% | +$3.47M | 0.01% | 800 |
|
|
2023
Q4 | $5.84M | Buy |
60,571
+59,760
| +7,369% | +$5.76M | 0.01% | 905 |
|
|
2023
Q3 | $71.8K | Sell |
811
-28,129
| -97% | -$2.49M | ﹤0.01% | 2128 |
|
|
2023
Q2 | $2.51M | Sell |
28,940
-437,747
| -94% | -$37.9M | ﹤0.01% | 1166 |
|
|
2023
Q1 | $45.4M | Buy |
466,687
+34,286
| +8% | +$3.33M | 0.08% | 359 |
|
|
2022
Q4 | $44.7M | Buy |
432,401
+427,438
| +8,612% | +$44.2M | 0.08% | 345 |
|
|
2022
Q3 | $420K | Sell |
4,963
-2,099
| -30% | -$178K | ﹤0.01% | 1624 |
|
|
2022
Q2 | $584K | Sell |
7,062
-17,898
| -72% | -$1.48M | ﹤0.01% | 1544 |
|
|
2022
Q1 | $1.92M | Buy |
24,960
+4,451
| +22% | +$343K | ﹤0.01% | 1523 |
|
|
2021
Q4 | $1.81M | Buy |
+20,509
| New | +$1.81M | ﹤0.01% | 1593 |
|